Characterization of the effects of butyric acid on cell proliferation, cell cycle distribution and apoptosis

FEMS Immunology and Medical Microbiology

Volumn 47, Issue 1, 2006, Pages 67-74

  Kurita Ochiai, Tomoko ^a   Hashizume, Tomomi ^a   Yonezawa, Hideo ^b   Ochiai, Kuniyasu ^c   Yamamoto, Masafumi ^a  

^a NIHON UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Showa University   (Japan)

Author keywords

Apoptosis; Butyric acid; Cell cycle; Cell growth

Indexed keywords

BUTYRIC ACID; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25C; COMPLEMENTARY DNA; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; BUTYRIC ACID; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; JURKAT CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES;

EID: 33646755383     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00066.x     Document Type: Article

References (35)

1. Alaskon C Miller F 1992 Selective events in the metastatic process defined by analysis of the sequential dissemination of a subpopulation of a mouse mammary tumor. Cancer Res 52: 1399 1405.
2. Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M Okamoto T 2001 Involvement of the interaction between p21 and proliferation cell nuclear antigen. J Biol Chem 276: 42971 42977.
3. Archer SY, Meng S, Shei A Hodin RA 1998 p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95: 6761 6796.
4. Battegay EJ, Roberts EW, Seifert RA, Bowen Pope DF Ross R 1990 TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63: 515 524.
5. Borrelli V, Antonio V, Sterpetti MD, Coluccia P, Randone B, Cavallaro A, Santoro D'Angelo L Cucina A 2001 Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture. J Surg Res 100: 154 160.
6. Botta GA, Radin L, Costa A Schito G 1985 Gas-liquid chromatography of the gingival fluid as an aid in periodontal diagnosis. J Periodont Res 20: 450 457.
7. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T Hannon GJ 1995 Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552 557.
8. Coradini D, Biffi A, Costa A, Pellizzaro C, Pirronello E Di Fronzo G 1997 Effect of sodium butyrate on human breast cancer cell lines. Cell Prolif 30: 149 159.
9. Coradini D, Pellizzaro C, Marimpietri D, Abolafio G Daidone MG 2000 Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells. Cell Prolif 33: 139 146.
10. Dulic V, Stein GH, Far DF Reed SI 1998 Nuclear accumulation of p21CIP1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 18: 546 557.
11. Dynlacht BD 1997 Regulation of transcription by proteins that control the cell cycle. Nature 389: 149 152.
12. Elledge SJ Harper JW 1994 Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 6: 847 852.
13. Feng XH, Filvaroff EH Derynck R 1995 Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem 270: 24237 24245.
14. Goldberg HJ, Huszar T, Mozes MM, Rosivall L Mucsi I 2002 Overexpression of the type II transforming growth factor-β receptor inhibits fibroblast proliferation and activates extracellular signal regulated kinase and C-Jun N-terminal kinase. Cell Biol Int 26: 165 174.
15. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM Piwnica-Worms H 2000 The chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 275: 5600 5605.
16. Hartwell LH Kastan MB 1994 Cell cycle control and cancer. Science 266: 1821 1828.
17. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J Pavletich NP 1995 Mechanisms of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376: 313 320.
18. Jeng JH, Chan CP, Ho YS, Lan WH, Hsieh CC Chang MC 1990 Effects of butyrate and propionate on the adhesion, growth, cell cycle kinetics, and protein synthesis of cultured human gingival fibroblasts. J Periodontol 70: 1435 1442.
19. Kurita-Ochiai T, Fukushima K Ochiai K 1997 Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells. Infect Immun 65: 35 41.
20. Kurita-Ochiai T, Fukushima K Ochiai K 1998 Volatile fatty acid, a metabolic by-product of periodontopathic bacteria, induces apoptosis in WEHI 231 and RAJI B lymphoma cells and splenic B cells. Infect Immun 66: 2587 2594.
21. Kurita-Ochiai T, Ochiai K Fukushima K 2001 Butyric acid-induced T cell apoptosis is mediated by caspase-8 and caspase-9 activation in a Fas-independent manner. Clin Diagn Lab Immunol 8: 325 332.
22. Mandal M Kumar R 1996 Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ 7: 311 318.
23. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM Bush HL 1995 Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to proliferative response to TGF-beta 1. J Clin Invest 96: 2667 2675.
24. Morgan DO 1995 Principal of CDK regulation. Nature 374: 131 134.
25. Paulsson Y, Karlsson C, Heldin CH Westermark B 1993 Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alpha-receptors. J Cell Physiol 157: 97 103.
26. Peter M Herskowitz I 1994 Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 181 184.
27. Pollanen MT, Overman DO Salonen JI 1997 Bacterial metabolites sodium butyrate and propionate inhibit epithelial cell growth in vitro. J Periodont Res 32 : 326 334.
28. Le Poul E, Loison C, Struyf S, et al 2003 Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278 : 25481 25489.
29. Sherr CJ 1996a Cancer cell cycle. Science 274 : 1472 1477.
30. Sherr CJ Roberts JM 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9 : 1149 1163.
31. Siavoshian S, Blottiere HM, Cherbut C Galmiche JP 1997 Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun 232 : 169 172.
32. Singhal PC, Reddy K, Franki N Ding G 1999 HIV-1 gp120 envelope protein modulates proliferation of human glomerular epithelial cells. J Cell Biochem 76 : 61 70.
33. St Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM Kerbel RS 1996 Impact of the cyclin-dependent kinase inhibitor p27KIP1 on resistance of tumor cells to anticancer agents. Nat Med 2 : 1204 1210.
34. Tonetti M, Eftimiadi C, Damiani G, Buffa P Botta GA 1987 Short chain fatty acids present in periodontal pockets may play a role in human periodontal diseases. J Periodont Res 22 : 190 191.
35. Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M Strebhardt K 2004 Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 23 : 5843 5852.